Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
European Journal of Nuclear Medicine and Molecular Imaging
November 21, 2017
Cited by 101
Related Papers
The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy
|Cell Communication and Signaling|2024|9